India to Netherlands: Bevacizumab Export Trade Route
India has recorded 21 verified shipments of Bevacizumab exported to Netherlands, representing a combined trade value of $6.7M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $320.5K USD. The leading Indian exporter is BIOCON BIOLOGICS INDIA LIMITED, which accounts for 100% of total export value with 19 shipments worth $6.7M USD. On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer in Netherlands with $3.9M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Bevacizumab corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $6.7M USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $320.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 31.0%, placing it at rank #17 among India's top bevacizumab export destinations globally.
On the import side, key buyers of Indian bevacizumab in Netherlands include BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX, XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX and 1 others. BIOCON BIOLOGICS UK LIMITED is the single largest importer with 11 shipments valued at $3.9M USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ4
- Primary modeSea freight
- Top portBioconsez
Market Position
- Global rank#17
- Annual growth+31.0%
- Demand growth+25.9%
- Regulatory ease82/100
Top 10 Indian Bevacizumab Exporters to Netherlands
Showing top 10 of 2 Indian suppliers exporting Bevacizumab to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS INDIA LIMITED Avg $353.8K per shipment | 19 | $6.7M | 99.9% |
| 2 | 3S CORPORATION Avg $3.6K per shipment | 2 | $7.2K | 0.1% |
This table shows the top 10 of 2 Indian companies exporting bevacizumab to Netherlands, ranked by total trade value. The listed exporters are: BIOCON BIOLOGICS INDIA LIMITED, 3S CORPORATION . BIOCON BIOLOGICS INDIA LIMITED is the dominant supplier with 19 shipments worth $6.7M USD, giving it a 100% market share.
Top 10 Bevacizumab Importers in Netherlands
Showing top 10 of 4 known buyers in Netherlands receiving Bevacizumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bevacizumab in Netherlands include BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX, XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX, FOR THE ORDER OF . The largest importer is BIOCON BIOLOGICS UK LIMITED, accounting for $3.9M USD across 11 shipments — representing 57% of all bevacizumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS UK LIMITED | 11 | $3.9M | 57.3% |
| 2 | XXOCOXXBIOXXGICXXUK XXMITXX | 6 | $2.7M | 39.6% |
| 3 | XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX | 2 | $202.1K | 3.0% |
| 4 | FOR THE ORDER OF | 2 | $7.2K | 0.1% |
Top 10 Bevacizumab Formulations Imported by Netherlands
Showing top 10 of 8 product formulations shipped on the India to Netherlands Bevacizumab route, ranked by trade value
Netherlands imports a wide range of bevacizumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ABEVMY 25 MG/ML BEVACIZUMAB — accounts for $3.2M USD across 9 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ABEVMY 25 MG/ML BEVACIZUMAB | 9 | $3.2M | 48.1% |
| 2 | ABEVMY 25 MG/ML (BEVACIZUMAB | 5 | $1.7M | 25.9% |
| 3 | ABEVMY 25 MG/ML (BEVACIZUMAB INJECTION | 1 | $647.0K | 9.6% |
| 4 | ABEVMY 25 MG/M (BEVACIZUMAB | 1 | $381.6K | 5.7% |
| 5 | ABEVMY 25 MG/M BEVACIZUMAB | 1 | $381.5K | 5.7% |
| 6 | ABEVMY 25 MG/ML BEVACIZUMAB | 2 | $338.1K | 5.0% |
| 7 | BEVACIZUMAB INJECTION 16ML/ 400 MG Compo | 1 | $4.2K | 0.1% |
| 8 | Bevacizumab Injection 100mg Composition | 1 | $3.0K | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Bioconsez handles the highest volume with 8 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's bevacizumab exports to Netherlands are driven primarily by a handful of large-scale manufacturers. BIOCON BIOLOGICS INDIA LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, 3S CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $320.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as abevmy 25 mg/ml (bevacizumab and abevmy 25 mg/ml (bevacizumab injection, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer with 11 shipments worth $3.9M USD — representing 57% of all bevacizumab imports from India on this route.
Route Statistics
- Trade Volume
- $6.7M
- Avg. Shipment
- $320.5K
- Suppliers
- 2
- Buyers
- 4
- Transit (Sea)
- ~26 days
- Annual Growth
- +31.0%
Related Analysis
Other Bevacizumab Routes
Unlock the Full India to Netherlands Bevacizumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 21 shipments on this route.
Frequently Asked Questions — India to Netherlands Bevacizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bevacizumab to Netherlands?
The leading Indian exporters of Bevacizumab to Netherlands are BIOCON BIOLOGICS INDIA LIMITED, 3S CORPORATION . BIOCON BIOLOGICS INDIA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Bevacizumab exports from India to Netherlands?
India exports Bevacizumab to Netherlands worth approximately $6.7M USD across 21 recorded shipments. The average value per shipment is $320.5K USD.
Q Which ports does India use to ship Bevacizumab to Netherlands?
The most active port of origin is Bioconsez with 8 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Netherlands for Bevacizumab?
The average transit time for Bevacizumab shipments from India to Netherlands is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Netherlands Bevacizumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.0% with demand growth tracking at 25.9%. The route is ranked #17 among India's top Bevacizumab export destinations globally.
Q How many suppliers are active on the India to Netherlands Bevacizumab route?
There are currently 2 active Indian suppliers exporting Bevacizumab to Netherlands. The market is moderately concentrated with BIOCON BIOLOGICS INDIA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Bevacizumab from India in Netherlands?
The leading importers of Indian Bevacizumab in Netherlands include BIOCON BIOLOGICS UK LIMITED, XXOCOXXBIOXXGICXXUK XXMITXX, XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX, FOR THE ORDER OF . BIOCON BIOLOGICS UK LIMITED is the largest buyer with 11 shipments worth $3.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Bevacizumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 4 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 21 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
21 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists